We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

High Court Ruling Can't Help Pfizer 'Win The Day' In Class Suit

Law360 (August 3, 2018, 10:28 PM EDT) -- An Illinois federal judge on Friday rejected Pfizer Inc.'s bid to dodge nationwide claims in a lawsuit alleging it overcharges for its "Maximum Strength" Robitussin, saying the U.S. Supreme Court's Bristol-Myers Squibb Co. v. Superior Court of California ruling can't "win the day" for the company.

U.S. District Judge Gary Feinerman said the high court's 2017 ruling, which addresses specific personal jurisdiction over absent class members, does not change the consensus that "due process neither preclude[s] nationwide or multistate class actions nor require[s] the absent-class-member-by-absent-class-member jurisdictional...
To view the full article, register now.




Case Information

Case Title

Al Haj et al v. Pfizer Inc

Case Number



Illinois Northern

Nature of Suit

110(Contract: Insurance)


Honorable Gary Feinerman

Date Filed

September 18, 2017

Law Firms


Government Agencies

Judge Analytics

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.